<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02133547</url>
  </required_header>
  <id_info>
    <org_study_id>CHUV-PNE-nNO-01</org_study_id>
    <nct_id>NCT02133547</nct_id>
  </id_info>
  <brief_title>Determination of Normal Values of Nasal Nitric Oxide in Adults</brief_title>
  <official_title>Determination of Normal Values of Nasal Nitric Oxide Measured With the NIOX MINO Analyzer in Adults: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterized by impaired airway&#xD;
      mucociliary clearance leading to recurrent respiratory infections, bronchiectasis and&#xD;
      eventually respiratory insufficiency. Diagnosis of PCD is difficult and relies on complex&#xD;
      methods which are not widely available (1).&#xD;
&#xD;
      Nasal nitric oxide (nNO) is reduced in PCD patients as compared to normal subjects, and nNO&#xD;
      measurement has been proposed as a non-invasive screening tool for PCD. However, nNO&#xD;
      measurement techniques are not standardized and reference values are lacking (2, 3).&#xD;
&#xD;
      The NIOX MINO is a handheld analyzer developed for the non-invasive measurement of exhaled NO&#xD;
      (eNO) in asthmatics. Measurement of nNO with the NIOX MINO has been reported in only few&#xD;
      studies (4-6), which mainly compared the NIOX MINO with others NO analyzers. However, no&#xD;
      study attempted to establish reference values with the NIOX MINO in a large number of normal&#xD;
      subjects.&#xD;
&#xD;
      One critical issue in nNO measurement is to avoid contamination of nasal air by exhaled&#xD;
      alveolar air during nNO sampling. This can be obtained by either breath holding, or by a&#xD;
      breathing technique allowing soft palate closure during sampling, such as mouth breathing&#xD;
      again resistance. However, as sampling times with the NIOX MINO are long (2 minutes at a flow&#xD;
      of 2 ml/min, and 45 seconds at a flow of 5 ml/min), these techniques may be difficult to&#xD;
      apply.&#xD;
&#xD;
      In this pilot study, we will determine normal nNO values in 100 healthy men and women aged 20&#xD;
      to 70 years using 3 different breathing techniques:&#xD;
&#xD;
        1. breath holding during 45 seconds&#xD;
&#xD;
        2. mouth breathing through a fixed resistance (a straw), to create a small positive&#xD;
           pressure in the oropharynx during expiration only&#xD;
&#xD;
        3. mouth breathing through a continuous positive airway pressure (CPAP) apparatus, which&#xD;
           produces continuous soft palate closure during quiet spontaneous breathing, thus&#xD;
           allowing long sampling times for nNO measurement.&#xD;
&#xD;
      This study will allow: 1) to determine whether nNO can be reliably measured with the NIOX&#xD;
      MINO in adult normal subjects, 2) to identify the most reproducible breathing technique, 3)&#xD;
      to determine normal values of nNO as measured by the NIOX MINO, and 4) to explore possible&#xD;
      differences between genders and age groups.&#xD;
&#xD;
      References:&#xD;
&#xD;
        1. J.S.A. Lucas, W.T. Walker, C.E. Kuehni and R. Lazor. Primary ciliary dyskinesia. Eur&#xD;
           Respir Mon. 2011; 54: 201-217.&#xD;
&#xD;
        2. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline&#xD;
           Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J&#xD;
           Respir Crit Care Med 2005; 171: 912-30.&#xD;
&#xD;
        3. Marthin JK, Nielsen KG. Choice of nasal nitric oxide technique as first-line test for&#xD;
           primary ciliary dyskinesia. Eur Respir J 2011; 37: 559-65.&#xD;
&#xD;
        4. Marthin JK, Nielsen KG. Hand-Held Tidal Breathing Nasal Nitric Oxide Measurement - A&#xD;
           Promising Targeted Case-Finding Tool for the Diagnosis of Primary Ciliary Dyskinesia.&#xD;
           PLoS ONE 2013; 8: e57262.&#xD;
&#xD;
        5. Weschta M, Deutschle T, Riechelmann H. Nasal fractional exhaled nitric oxide analysis&#xD;
           with a novel hand-held device. Rhinology 2008; 46: 23-7.&#xD;
&#xD;
        6. Maniscalco M, Laurentiis G de, Weitzberg E, Lundberg JO, Sofia M. Validation study of&#xD;
           nasal nitric oxide measurements using a hand-held electrochemical analyser. Eur J Clin&#xD;
           Invest 2008; 38: 197-200.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>nitric oxide concentration in the air flowing through the nasal cavities</measure>
    <time_frame>sampling time: 45 seconds</time_frame>
    <description>The NIOX MINO is a handheld analyzer allowing determination of nitric oxide in an air sample. The sample is obtained non-invasively by breathing in the device through the mouth or nose.</description>
  </primary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Normal Values of Nasal Nitric Oxide in Healthy Adults</condition>
  <eligibility>
    <study_pop>
      <textblock>
        healthy subjects&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  consent signed&#xD;
&#xD;
          -  adult healthy subjects&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  current smoker&#xD;
&#xD;
          -  history of asthma&#xD;
&#xD;
          -  history of acute or chronic sinusitis&#xD;
&#xD;
          -  history of nasal polyps&#xD;
&#xD;
          -  upper airway infection in the past 3 weeks&#xD;
&#xD;
          -  use of nasal corticosteroids in the past 3 weeks&#xD;
&#xD;
          -  cleft palate&#xD;
&#xD;
          -  history of uvulopharyngopalatoplasty&#xD;
&#xD;
          -  history of neuromuscular disorder&#xD;
&#xD;
          -  history of chronic respiratory disease, including cystic fibrosis and primary ciliary&#xD;
             dyskinesia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romain Lazor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lausanne University Hospital (CHUV)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Respiratory Department Lausanne University Hospital</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Maniscalco M, de Laurentiis G, Weitzberg E, Lundberg JO, Sofia M. Validation study of nasal nitric oxide measurements using a hand-held electrochemical analyser. Eur J Clin Invest. 2008 Mar;38(3):197-200. doi: 10.1111/j.1365-2362.2008.01907.x.</citation>
    <PMID>18257783</PMID>
  </reference>
  <reference>
    <citation>Weschta M, Deutschle T, Riechelmann H. Nasal fractional exhaled nitric oxide analysis with a novel hand-held device. Rhinology. 2008 Mar;46(1):23-7.</citation>
    <PMID>18444488</PMID>
  </reference>
  <reference>
    <citation>Marthin JK, Nielsen KG. Hand-held tidal breathing nasal nitric oxide measurement--a promising targeted case-finding tool for the diagnosis of primary ciliary dyskinesia. PLoS One. 2013;8(2):e57262. doi: 10.1371/journal.pone.0057262. Epub 2013 Feb 20.</citation>
    <PMID>23437356</PMID>
  </reference>
  <reference>
    <citation>Montella S, Alving K, Maniscalco M, Sofia M, De Stefano S, Raia V, Santamaria F. Measurement of nasal nitric oxide by hand-held and stationary devices. Eur J Clin Invest. 2011 Oct;41(10):1063-70. doi: 10.1111/j.1365-2362.2011.02501.x. Epub 2011 Mar 17.</citation>
    <PMID>21413977</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>May 7, 2014</study_first_submitted>
  <study_first_submitted_qc>May 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2014</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Dr. Romain Lazor</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Nitric Oxide</keyword>
  <keyword>Nose</keyword>
  <keyword>Healthy Volunteers</keyword>
  <keyword>Kartagener Syndrome</keyword>
  <keyword>Primary Ciliary Dyskinesia</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

